The local medical sector is excited with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor showing impressive results in early trials for managing obesity. This therapy suggests a https://isocialfans.com/story7363513/the-new-retatrutide-australia-a-potential-hope-for-weight-management